| Q38797022 | A SILAC-Based Approach Elicits the Proteomic Responses to Vancomycin-Associated Nephrotoxicity in Human Proximal Tubule Epithelial HK-2 Cells. |
| Q37706507 | A novel benzimidazole derivative, MBIC inhibits tumor growth and promotes apoptosis via activation of ROS-dependent JNK signaling pathway in hepatocellular carcinoma |
| Q38699450 | ANTICANCER ACTIVITY OF 5, 7-DIMETHOXYFLAVONE AGAINST LIVER CANCER CELL LINE HEPG2 INVOLVES APOPTOSIS, ROS GENERATION AND CELL CYCLE ARREST. |
| Q33691759 | Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies |
| Q31088405 | Anti-proliferative effect of methanolic extract of Gracilaria tenuistipitata on oral cancer cells involves apoptosis, DNA damage, and oxidative stress. |
| Q49482625 | Anticancer activity of 23,24-dihydrocucurbitacin B against the HeLa human cervical cell line is due to apoptosis and G2/M cell cycle arrest |
| Q50047780 | Anticancer activity of caffeic acid n‑butyl ester against A431 skin carcinoma cell line occurs via induction of apoptosis and inhibition of the mTOR/PI3K/AKT signaling pathway |
| Q90447324 | Anticancer activity of sugiol against ovarian cancer cell line SKOV3 involves mitochondrial apoptosis, cell cycle arrest and blocking of the RAF/MEK/ERK signalling pathway |
| Q34602854 | Antineoplastic effects of α-santalol on estrogen receptor-positive and estrogen receptor-negative breast cancer cells through cell cycle arrest at G2/M phase and induction of apoptosis |
| Q48831857 | Apoptosis and proliferation: correlation with p53 in astrocytic tumours |
| Q40162436 | Apoptosis assays with lymphoma cell lines: problems and pitfalls |
| Q35893996 | Classification of scaffold-hopping approaches |
| Q64057639 | Cytotoxicity and cell cycle analysis of Asparagus laricinus Burch. and Senecio asperulus DC. on breast and prostate cancer cell lines |
| Q89986458 | Cytotoxicity and cell death induced by engineered nanostructures (quantum dots and nanoparticles) in human cell lines |
| Q31077911 | Data mining of NCI's anticancer screening database reveals mitochondrial complex I inhibitors cytotoxic to leukemia cell lines |
| Q38699551 | Deoxyelephantopin and Isodeoxyelephantopin as Potential Anticancer Agents with Effects on Multiple Signaling Pathways. |
| Q90533419 | Disruption of mitochondrial homeostasis with artemisinin unravels anti-angiogenesis effects via auto-paracrine mechanisms |
| Q46778603 | Downregulation of PI3-K/Akt/PTEN pathway and activation of mitochondrial intrinsic apoptosis by Diclofenac and Curcumin in colon cancer |
| Q38985136 | Dracorhodin perchlorate induces G1/G0 phase arrest and mitochondria-mediated apoptosis in SK-MES-1 human lung squamous carcinoma cells |
| Q21202788 | Edelfosine-induced metabolic changes in cancer cells that precede the overproduction of reactive oxygen species and apoptosis |
| Q38825815 | Effect of metformin on the human T98G glioblastoma multiforme cell line |
| Q37694828 | Enhancement of 5-FU sensitivity by the proapoptotic rpL3 gene in p53 null colon cancer cells through combined polymer nanoparticles |
| Q93048429 | Evaluation of cytotoxicity, cell cycle arrest and apoptosis induced by Anethum graveolens L. essential oil in human hepatocellular carcinoma cell line |
| Q49739803 | Fucosterol exhibits selective antitumor anticancer activity against HeLa human cervical cell line by inducing mitochondrial mediated apoptosis, cell cycle migration inhibition and downregulation of m-TOR/PI3K/Akt signalling pathway |
| Q35856684 | Guggulsterone inhibits human cholangiocarcinoma Sk-ChA-1 and Mz-ChA-1 cell growth by inducing caspase-dependent apoptosis and downregulation of survivin and Bcl-2 expression |
| Q39056096 | In vitro and in vivo anti-cancer activity of formononetin on human cervical cancer cell line HeLa |
| Q36424294 | In vitro and in vivo growth inhibition of drug-resistant ovarian carcinoma cells using a combination of cisplatin and a TRAIL-encoding retrovirus |
| Q42183913 | Increased expression of the lipocalin 24p3 as an apoptotic mechanism for MK886. |
| Q28483410 | Inhibitory effects and underlying mechanism of 7-hydroxyflavone phosphate ester in HeLa cells |
| Q35827410 | Is there any correlation between TNF-related apoptosis-inducing ligand (TRAIL) genetic variants and breast cancer? |
| Q39861400 | Isothiocyanates sensitize the effect of chemotherapeutic drugs via modulation of protein kinase C and telomerase in cervical cancer cells |
| Q26773408 | Killing cancer with platycodin D through multiple mechanisms |
| Q40000949 | Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer |
| Q80619467 | Livin and Bcl-2 expression in high-grade osteosarcoma |
| Q34541960 | Lung cancer therapeutics that target signaling pathways: an update |
| Q89538271 | Molecular Mechanisms of Anticancer Activities of Puerarin |
| Q47108019 | N-myc downstream-regulated gene 1 promotes apoptosis in colorectal cancer via up-regulating death receptor 4. |
| Q24619151 | New insights into the mechanisms of green tea catechins in the chemoprevention of prostate cancer |
| Q38876796 | Novel all trans-retinoic Acid derivatives: cytotoxicity, inhibition of cell cycle progression and induction of apoptosis in human cancer cell lines. |
| Q38561065 | Novel piperazine induces apoptosis in U937 cells. |
| Q61811902 | Novel triazole analogs of apigenin-7-methyl ether exhibit potent antitumor activity against ovarian carcinoma cells via the induction of mitochondrial-mediated apoptosis |
| Q42278494 | Overexpression of Bcl2 abrogates chemo- and radiotherapy-induced sensitisation of NCI-H460 non-small-cell lung cancer cells to adenovirus-mediated expression of full-length TRAIL. |
| Q36104764 | Overexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma |
| Q28385880 | Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells |
| Q37673329 | Potential therapeutic targets of Guggulsterone in cancer |
| Q35054432 | Potentiation of tumor radiotherapy by a radiation-inducible oncolytic and oncoapoptotic adenovirus in cervical cancer xenografts |
| Q28388409 | Proteomic response to 5,6-dimethylxanthenone 4-acetic acid (DMXAA, vadimezan) in human non-small cell lung cancer A549 cells determined by the stable-isotope labeling by amino acids in cell culture (SILAC) approach |
| Q34313135 | Radiotherapy sensitization by tumor-specific TRAIL gene targeting improves survival of mice bearing human non-small cell lung cancer |
| Q24801155 | Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin |
| Q41851454 | Stevioside induced cytotoxicity in colon cancer cells via reactive oxygen species and mitogen-activated protein kinase signaling pathways-mediated apoptosis |
| Q36126660 | Synergistic antitumor effects of liposomal honokiol combined with cisplatin in colon cancer models |
| Q40777873 | The Curcumin Analogue 1,5-Bis(2-hydroxyphenyl)-1,4-pentadiene-3-one Induces Apoptosis and Downregulates E6 and E7 Oncogene Expression in HPV16 and HPV18-Infected Cervical Cancer Cells. |
| Q92286881 | The New Compound of (2R, 4S)-N-(2, 5-difluorophenyl)-4-Hydroxy-1-(2, 2, 2-Trifluoroacetyl) Pyrrolidine-2-Carboxamide to Mediate the Expression of Some Apoptosis Genes by the HepG2 Cell Line |
| Q40273985 | The role of Ca2+ on the DADS-induced apoptosis in mouse-rat hybrid retina ganglion cells (N18). |
| Q39294188 | Towards novel anti-tumor strategies for hepatic cancer: ɛ-viniferin in combination with vincristine displays pharmacodynamic synergy at lower doses in HepG2 cells |
| Q37067216 | Tubeimoside-1 induces oxidative stress-mediated apoptosis and G0/G1 phase arrest in human prostate carcinoma cells in vitro |
| Q34595455 | Tumor-specific apoptotic gene targeting overcomes radiation resistance in esophageal adenocarcinoma |
| Q28751681 | Vitamin E analogues as inducers of apoptosis: structure-function relation |
| Q38694216 | Withaferin-A Induces Apoptosis in Osteosarcoma U2OS Cell Line via Generation of ROS and Disruption of Mitochondrial Membrane Potential |
| Q34225131 | c-Jun NH2-terminal kinase-induced proteasomal degradation of c-FLIPL/S and Bcl2 sensitize prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrine |